1-2 of 2
Mary B Callanan, PhD
Close
Sort by
Journal Articles

Predictive Power of Early, Sequential MRD Monitoring in Peripheral Blood and Bone Marrow in Patients with Mantle Cell Lymphoma Following Autologous Stem Cell Transplantation with or without Rituximab Maintenance; Final Results from the LyMa-MRD Project, Conducted on Behalf of the Lysa Group

Mary B. Callanan, PhD, Elizabeth Macintyre, PhD MD, Marie-Helene Delfau-Larue, MD PhD, Catherine Thieblemont, MD PhD, Lucie Oberic, MD, Emmanuel Gyan, MD PhD, Krimo Bouabdallah, MD, Rémy Gressin, MD, Gandhi Damaj, MD PhD, Olivier Casasnovas, MD, Vincent Ribrag, MD, Samuel Griolet, Bénédicte Burlet, Benjamin Tournier, PhD, Sylviane Ragot, M.Sc, Caroline Bodet-Milin, Olivier Hermine, Steven Le Gouill, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 12–13.
https://doi.org/10.1182/blood-2020-140457
Published: 2020
Journal Articles

Predictive Power of Early, Sequential MRD Monitoring in Peripheral Blood and Bone Marrow in Patients with Mantle Cell Lymphoma Following Autologous Stem Cell Transplantation with or without Rituximab Maintenance; Interim Results from the LyMa-MRD Project, Conducted on Behalf of the Lysa Group

Mary B Callanan, PhD, Marie-Hélène Delfau, MD PhD, Elizabeth Macintyre, MD PhD, Catherine Thieblemont, Lucie Oberic, MD, Emmanuel Gyan, MD PhD, Krimo Bouabdallah, MD, Remy Gressin, MD, Gandhi Damaj, MD PhD, Olivier Casasnovas, MD, Vincent Ribrag, MD, Estelle Gimenez, MSc, Olivier Hermine, Steven Le Gouill, MD PhD
Journal: Blood
Blood (2015) 126 (23): 338.
https://doi.org/10.1182/blood.V126.23.338.338
Published: 2015